Cargando…
Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience
[Image: see text] Background: Coronavirus disease 2019 (COVID-19), a multi-system disorder resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected 5.0 million individuals in the United States (US) resulting in more than 160,000 deaths. There is curren...
Autores principales: | Browning, Sabrina L., Gormally, Michael, Briggs, Neima, Li, Muyi, Zakko, Alan, Laurent-Rolle, Maudry, Ladines-Lim, Joseph, Morrison, Alyssa, Kandel, Prakash, Khan, Mohammad, McLeod, Gavin X., Buller, Gregory K., Owusu, Kent A., Treggiari, Miriam M., Hendrickson, Jeanne E., Tormey, Christopher A., Desruisseaux, Mahalia S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330251/ http://dx.doi.org/10.1182/blood-2020-137352 |
Ejemplares similares
-
Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors
por: Baez Sosa, Valentina, et al.
Publicado: (2021) -
Early but not late convalescent plasma is associated with better survival in moderate-to-severe COVID-19
por: Briggs, Neima, et al.
Publicado: (2021) -
COVID-19 Vaccination Motivation and Hesitancy in Heart Transplant Recipients During a Global Health Crisis
por: Mohney, K.L., et al.
Publicado: (2022) -
Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience.
por: Plaza, Carlos, et al.
Publicado: (2020) -
Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic
por: Baez Sosa, Valentina, et al.
Publicado: (2020)